GB9918606D0 - Novel peptides - Google Patents

Novel peptides

Info

Publication number
GB9918606D0
GB9918606D0 GBGB9918606.6A GB9918606A GB9918606D0 GB 9918606 D0 GB9918606 D0 GB 9918606D0 GB 9918606 A GB9918606 A GB 9918606A GB 9918606 D0 GB9918606 D0 GB 9918606D0
Authority
GB
United Kingdom
Prior art keywords
novel peptides
peptides
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9918606.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Holding Ltd
Original Assignee
Peptide Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptide Therapeutics Ltd filed Critical Peptide Therapeutics Ltd
Priority to GBGB9918606.6A priority Critical patent/GB9918606D0/en
Publication of GB9918606D0 publication Critical patent/GB9918606D0/en
Priority to BR0008964-8A priority patent/BR0008964A/en
Priority to HU0105490A priority patent/HUP0105490A3/en
Priority to MXPA01008612A priority patent/MXPA01008612A/en
Priority to PL00350992A priority patent/PL350992A1/en
Priority to PCT/EP2000/001456 priority patent/WO2000050461A1/en
Priority to AU32811/00A priority patent/AU3281100A/en
Priority to IL14502500A priority patent/IL145025A0/en
Priority to EP00910690A priority patent/EP1155038A1/en
Priority to CA002363641A priority patent/CA2363641A1/en
Priority to CNA008067562A priority patent/CN1520423A/en
Priority to NZ513680A priority patent/NZ513680A/en
Priority to TR2001/02493T priority patent/TR200102493T2/en
Priority to KR1020017010940A priority patent/KR20020007314A/en
Priority to CZ20013081A priority patent/CZ20013081A3/en
Priority to JP2000601039A priority patent/JP2002537403A/en
Priority to ARP000100821A priority patent/AR029619A1/en
Priority to CO00013386A priority patent/CO5231139A1/en
Priority to NO20014131A priority patent/NO20014131L/en
Priority to HK02103181.1A priority patent/HK1043134A1/en
Priority to US10/304,443 priority patent/US20030170229A1/en
Priority to US10/322,210 priority patent/US20030147906A1/en
Priority to US11/004,771 priority patent/US20050152892A1/en
Ceased legal-status Critical Current

Links

GBGB9918606.6A 1999-02-25 1999-08-07 Novel peptides Ceased GB9918606D0 (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
GBGB9918606.6A GB9918606D0 (en) 1999-08-07 1999-08-07 Novel peptides
JP2000601039A JP2002537403A (en) 1999-02-25 2000-02-22 Epitopes or mimotopes from the C-epsilon-3 or C-epsilon-4 domain of IgE, antagonists thereof, and their therapeutic uses
CNA008067562A CN1520423A (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from C-eqsilon-3, or C-epsilon-4 domains of ige, antagonists thereof, and their thera peutic uses
TR2001/02493T TR200102493T2 (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the C-epsilon-3 or C-epsilon-4 domains of IgE.
MXPA01008612A MXPA01008612A (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses.
PL00350992A PL350992A1 (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
PCT/EP2000/001456 WO2000050461A1 (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
AU32811/00A AU3281100A (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
IL14502500A IL145025A0 (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
EP00910690A EP1155038A1 (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
CA002363641A CA2363641A1 (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
BR0008964-8A BR0008964A (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the ige dec-epsilon-3 or c-epsilon-4 fields, antagonists of the same and their therapeutic uses
NZ513680A NZ513680A (en) 1999-02-25 2000-02-22 Epitodes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of IgE, antagonists thereof, and their therapeutic uses
HU0105490A HUP0105490A3 (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
KR1020017010940A KR20020007314A (en) 1999-02-25 2000-02-22 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
CZ20013081A CZ20013081A3 (en) 1999-02-25 2000-02-22 Epitopes and a extratopes obtained from C-epsilon-2 region or C-epsilon-4 IgE region, their antagonists a their therapeutic use
CO00013386A CO5231139A1 (en) 1999-02-25 2000-02-25 ALLERGIC VACCINE
ARP000100821A AR029619A1 (en) 1999-02-25 2000-02-25 VACCINE
NO20014131A NO20014131L (en) 1999-02-25 2001-08-24 Epitopes or mimotopes derived from C-epsilon-3 or C-epsilon-4 domains from IgE, antagonists thereof, and derester therapeutic applications
HK02103181.1A HK1043134A1 (en) 1999-02-25 2002-04-29 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
US10/304,443 US20030170229A1 (en) 1999-02-25 2002-11-26 Vaccine
US10/322,210 US20030147906A1 (en) 1999-07-21 2002-12-18 Epitopes or mimotopes derived from the C-epsilon-3 or C-epsilon-4 domains of lgE, antagonists thereof, and their therapeutic uses
US11/004,771 US20050152892A1 (en) 1999-07-21 2004-12-03 Epitopes or mimotopes derived from the C-epsilon-3 or C-epsilon-4 domains of IgE, antagonists thereof, and their therapeutics uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9918606.6A GB9918606D0 (en) 1999-08-07 1999-08-07 Novel peptides

Publications (1)

Publication Number Publication Date
GB9918606D0 true GB9918606D0 (en) 1999-10-13

Family

ID=10858739

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9918606.6A Ceased GB9918606D0 (en) 1999-02-25 1999-08-07 Novel peptides

Country Status (1)

Country Link
GB (1) GB9918606D0 (en)

Similar Documents

Publication Publication Date Title
GB9912852D0 (en) Peptides
GB9923177D0 (en) Novel polypeptide
EP1173467A4 (en) Chemokine-derived synthetic peptides
GB9918156D0 (en) Synthetic peptides
EP1147130A4 (en) Alpha-conotoxin peptides
GB9923889D0 (en) Novel polypeptide
EP1159288A4 (en) Alpha-conotoxin peptides
GB9904695D0 (en) Peptide
EP1162269A4 (en) Novel polypeptide
GB9924951D0 (en) Novel polypeptide
EP1179540A4 (en) Novel polypeptide
IL144376A0 (en) Peptides
GB9908920D0 (en) Peptide
GB9923893D0 (en) Novel polypeptide
GB9923890D0 (en) Novel polypeptide
EP1151100A4 (en) Tau-conotoxin peptides
GB9923888D0 (en) Novel polypeptide
GB9925115D0 (en) Novel polypeptide
GB9924960D0 (en) Novel polypeptide
GB9918595D0 (en) Novel peptides
GB9918597D0 (en) Novel peptides
GB9918598D0 (en) Novel peptides
GB9918596D0 (en) Novel peptides
GB9918599D0 (en) Novel peptides
GB9918594D0 (en) Novel peptides

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)